251 related articles for article (PubMed ID: 19432117)
1. [Evidence for the selective estrogen receptor modulator raloxifene--its pharmacological characteristics, efficacy and safety profiles].
Ohta H
Nihon Rinsho; 2009 May; 67(5):960-6. PubMed ID: 19432117
[TBL] [Abstract][Full Text] [Related]
2. [Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
Ohta H
Clin Calcium; 2008 Oct; 18(10):1442-50. PubMed ID: 18830041
[TBL] [Abstract][Full Text] [Related]
3. [Effects of SERMs on bone health. Evidence for the selective estrogen receptor modulator raloxifene: its evolving role in the treatment of osteoporosis].
Ohta H
Clin Calcium; 2010 Mar; 20(3):315-21. PubMed ID: 20190360
[TBL] [Abstract][Full Text] [Related]
4. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
Ohta H
Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
[TBL] [Abstract][Full Text] [Related]
5. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
Ohta H
Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
[TBL] [Abstract][Full Text] [Related]
6. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?
Sambrook P
Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191
[TBL] [Abstract][Full Text] [Related]
7. [SERMs: an update for clinicians].
Ohta H
Clin Calcium; 2005 Apr; 15(4):637-42. PubMed ID: 15802777
[TBL] [Abstract][Full Text] [Related]
8. [Effects of raloxifene on bone loss and fracture risk in the menopausal woman].
Vignot E; Meunier PJ
Contracept Fertil Sex; 1999 Dec; 27(12):858-60. PubMed ID: 10676043
[TBL] [Abstract][Full Text] [Related]
9. [Drug treatment for the treatment of primary osteoporosis].
Halbekath J
Z Arztl Fortbild Qualitatssich; 2000 Aug; 94(6):453-60. PubMed ID: 10996934
[TBL] [Abstract][Full Text] [Related]
10. [SERM and quality of bone].
Sohen S
Clin Calcium; 2004 Oct; 14(10):96-9. PubMed ID: 15577138
[TBL] [Abstract][Full Text] [Related]
11. [Effect of raloxifene as a SERM on bone metabolism].
Ohta H
Nihon Rinsho; 2006 Apr; 64 Suppl 4():411-8. PubMed ID: 16689343
[No Abstract] [Full Text] [Related]
12. [Raloxifene and bone quality issues].
Ohta H
Clin Calcium; 2005 Jun; 15(6):1012-9. PubMed ID: 15930716
[TBL] [Abstract][Full Text] [Related]
13. [Effects of SERMs on bone health. Discrimination of SERMs from bisphosphonates in the treatment of postmenopausal osteoporosis].
Iwamoto J
Clin Calcium; 2010 Mar; 20(3):396-407. PubMed ID: 20190370
[TBL] [Abstract][Full Text] [Related]
14. [Selective estrogen receptor modulator].
Ohta H
Clin Calcium; 2004 Jan; 14(1):165-72. PubMed ID: 15576973
[TBL] [Abstract][Full Text] [Related]
15. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women.
Lee WL; Chao HT; Cheng MH; Wang PH
Maturitas; 2008 Jun; 60(2):92-107. PubMed ID: 18534794
[TBL] [Abstract][Full Text] [Related]
16. [Anabolic treatment for osteoporosis: PTH treatment].
Kaji H; Sugimoto T
Clin Calcium; 2006 Sep; 16(9):1480-85. PubMed ID: 16951472
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of osteoporosis: overview].
Nakamura T
Nihon Rinsho; 2002 Mar; 60 Suppl 3():273-9. PubMed ID: 11979919
[No Abstract] [Full Text] [Related]
18. [Who are the candidates for the treatment by raloxifen ?].
Hagino H
Clin Calcium; 2004 Oct; 14(10):111-3. PubMed ID: 15577141
[TBL] [Abstract][Full Text] [Related]
19. [Raloxifene (Celvista, Evista)].
Body JJ; Sternon J
Rev Med Brux; 2000 Feb; 21(1):35-41. PubMed ID: 10748686
[TBL] [Abstract][Full Text] [Related]
20. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
Saito M
Clin Calcium; 2010 Mar; 20(3):345-54. PubMed ID: 20190364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]